NFATc1 Promotes Prostate Tumorigenesis and Overcomes PTEN Loss-Induced Senescence

[1]  Yi Li,et al.  The role of NFATc1 in prostate cancer progression: Cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion , 2015, The Prostate.

[2]  Zhongming Zhao,et al.  Key regulators in prostate cancer identified by co-expression module analysis , 2014, BMC Genomics.

[3]  Z. Culig.  Proinflammatory cytokine interleukin-6 in prostate carcinogenesis. , 2014, American journal of clinical and experimental urology.

[4]  C. Creighton,et al.  VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2 , 2014, Oncogene.

[5]  A. Tewari,et al.  Inflammation and prostate cancer: the role of interleukin 6 (IL‐6) , 2014, BJU international.

[6]  A. Carnero,et al.  The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models , 2014, Front. Oncol..

[7]  E. Antonarakis,et al.  Castration-resistant prostate cancer: latest evidence and therapeutic implications , 2014, Therapeutic advances in medical oncology.

[8]  J. Pfeifer,et al.  Activation of NFAT signaling establishes a tumorigenic microenvironment through cell autonomous and non-cell autonomous mechanisms , 2014, Oncogene.

[9]  R. Agarwal,et al.  Silibinin inhibits prostate cancer cells‐ and RANKL‐induced osteoclastogenesis by targeting NFATc1, NF‐κB, and AP‐1 activation in RAW264.7 cells , 2014, Molecular carcinogenesis.

[10]  S. Komarova,et al.  Molecular Signaling Pathways Mediating Osteoclastogenesis Induced by Prostate Cancer Cells , 2013, BMC Cancer.

[11]  M. Moore,et al.  Genomic Rearrangements of PTEN in Prostate Cancer , 2013, Front. Oncol..

[12]  M. Pan,et al.  NFAT gene family in inflammation and cancer. , 2013, Current molecular medicine.

[13]  Lianfeng Zhang,et al.  STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells. , 2013, Cellular signalling.

[14]  M. Serrano,et al.  PTEN in cancer, metabolism, and aging , 2013, Trends in Endocrinology & Metabolism.

[15]  Daniel J. Devine,et al.  Cytoplasmic translocation of p21 mediates NUPR1‐induced chemoresistance , 2012, FEBS letters.

[16]  Wenrong Zhao,et al.  Stat3 induces oncogenic Skp2 expression in human cervical carcinoma cells. , 2012, Biochemical and biophysical research communications.

[17]  L. Trusolino,et al.  Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils , 2011, EMBO molecular medicine.

[18]  A. Toker,et al.  NFAT promotes carcinoma invasive migration through glypican-6 , 2011, The Biochemical journal.

[19]  Frank McCormick,et al.  Cancer therapy based on oncogene addiction , 2011, Journal of surgical oncology.

[20]  Gerald C. Chu,et al.  SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression , 2011, Nature.

[21]  Feng Chen,et al.  Activation of NFAT signaling in podocytes causes glomerulosclerosis. , 2010, Journal of the American Society of Nephrology : JASN.

[22]  Vassiliki Tzelepi,et al.  Therapeutic targeting of the prostate cancer microenvironment , 2010, Nature Reviews Urology.

[23]  C. Sander,et al.  Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.

[24]  E. Agardh,et al.  Nuclear Factor of Activated T‐cells (NFAT) regulates osteopontin expression in arterial smooth muscle in response to diabetes‐induced hyperglycemia , 2010 .

[25]  A. Kozubík,et al.  Breast cancer-specific mutations in CK1ε inhibit Wnt/β-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration , 2010, Breast Cancer Research.

[26]  Manoj Bhasin,et al.  Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer , 2009, Clinical Cancer Research.

[27]  L. Lagunas,et al.  Deregulated NFATc1 activity transforms murine fibroblasts via an autocrine growth factor‐mediated Stat3‐dependent pathway , 2009, Journal of cellular biochemistry.

[28]  J. Viola,et al.  Dual Roles for NFAT Transcription Factor Genes as Oncogenes and Tumor Suppressors , 2008, Molecular and Cellular Biology.

[29]  Yahui Kong,et al.  Suppression of human tumor cell proliferation by Smurf2‐induced senescence , 2008, Journal of cellular physiology.

[30]  C. Alberti.  Genetic and microenvironmental implications in prostate cancer progression and metastasis. , 2008, European review for medical and pharmacological sciences.

[31]  A. Joe,et al.  Oncogene addiction. , 2008, Cancer research.

[32]  N. Prevarskaya,et al.  TRPV6 channel controls prostate cancer cell proliferation via Ca2+/NFAT-dependent pathways , 2007, Oncogene.

[33]  G. Crabtree,et al.  Enhanced NFATc1 Nuclear Occupancy Causes T Cell Activation Independent of CD28 Costimulation1 , 2007, The Journal of Immunology.

[34]  T. Gress,et al.  Overexpression of c‐myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway , 2006, The EMBO journal.

[35]  A. Toker,et al.  NFAT Induces Breast Cancer Cell Invasion by Promoting the Induction of Cyclooxygenase-2* , 2006, Journal of Biological Chemistry.

[36]  A. Toker,et al.  Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. , 2005, Molecular cell.

[37]  J. Whitsett,et al.  Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction , 2005, Nucleic acids research.

[38]  C. Kao,et al.  NFATc1 with AP-3 site binding specificity mediates gene expression of prostate-specific-membrane-antigen. , 2003, Journal of molecular biology.

[39]  J. Neal,et al.  A Constitutively Active NFATc1 Mutant Induces a Transformed Phenotype in 3T3-L1 Fibroblasts* , 2003, The Journal of Biological Chemistry.

[40]  M. Blagosklonny.  Are p27 and p21 Cytoplasmic Oncoproteins? , 2002, Cell cycle.

[41]  Leslie M. Shaw,et al.  The role of NFAT transcription factors in integrin-mediated carcinoma invasion , 2002, Nature Cell Biology.

[42]  I. Graef,et al.  NFAT signaling in vertebrate development. , 2001, Current opinion in genetics & development.

[43]  T. Yeatman,et al.  Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Roy-Burman,et al.  Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation , 2001, Mechanisms of Development.

[45]  T. Hirano,et al.  Stat3 Is Required for the Gp130-mediated Full Activation of the C-myc Gene , 1999 .

[46]  P. Briand,et al.  The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors. , 1975, Cancer research.